Bentur Y - Search Results

1

Colchicine poisoning: the dark side of an ancient drug.

Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y. Finkelstein Y, et al. Among authors: bentur y. Clin Toxicol (Phila). 2010 Jun;48(5):407-14. doi: 10.3109/15563650.2010.495348. Clin Toxicol (Phila). 2010. PMID: 20586571 Review.

2

"Doctor, will that x-ray harm my unborn child?".

Ratnapalan S, Bentur Y, Koren G. Ratnapalan S, et al. Among authors: bentur y. CMAJ. 2008 Dec 2;179(12):1293-6. doi: 10.1503/cmaj.080247. CMAJ. 2008. PMID: 19047611 Free PMC article. Review.

3

The three most common occupational exposures reported by pregnant women: an update.

Bentur Y, Koren G. Bentur Y, et al. Am J Obstet Gynecol. 1991 Aug;165(2):429-37. doi: 10.1016/0002-9378(91)90112-5. Am J Obstet Gynecol. 1991. PMID: 1872354 Review.

4

An unusual skin exposure to copper; clinical and pharmacokinetic evaluation.

Bentur Y, Koren G, McGuigan M, Spielberg SP. Bentur Y, et al. J Toxicol Clin Toxicol. 1988;26(5-6):371-80. doi: 10.1080/15563658809167101. J Toxicol Clin Toxicol. 1988. PMID: 3193491

5

Universal versus selective iron supplementation for infants and the risk of unintentional poisoning in young children: a comparative study of two populations.

Finkelstein Y, Wahl MS, Bentur Y, Schechter T, Garty BZ, Erickson TB, Chodick G, Cahana A, Mounstephen BJ, Koren G, Aks SE. Finkelstein Y, et al. Among authors: bentur y. Ann Pharmacother. 2007 Mar;41(3):414-9. doi: 10.1345/aph.1H346. Epub 2007 Mar 6. Ann Pharmacother. 2007. PMID: 17341538

6

Misinterpretation of iron-binding capacity in the presence of deferoxamine.

Bentur Y, St Louis P, Klein J, Koren G. Bentur Y, et al. J Pediatr. 1991 Jan;118(1):139-42. doi: 10.1016/s0022-3476(05)81868-2. J Pediatr. 1991. PMID: 1986082 No abstract available.

7

Methodological issues in studying the effect of the new oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) on absorption of iron.

Bentur Y, Klein J, Levy M, Olivieri N, McGuigan M, Koren G. Bentur Y, et al. Vet Hum Toxicol. 1990 Apr;32(2):159-61. Vet Hum Toxicol. 1990. PMID: 2327067

8

Biological and toxic properties of deferoxamine.

Freedman MH, Bentur Y, Koren G. Freedman MH, et al. Among authors: bentur y. Prog Clin Biol Res. 1989;309:115-24. Prog Clin Biol Res. 1989. PMID: 2675081 Review. No abstract available.

9

Comparison of the pharmacokinetics of 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in healthy volunteers, with and without co-administration of ferrous sulfate, to thalassemia patients.

Stobie S, Tyberg J, Matsui D, Fernandes D, Klein J, Olivieri N, Bentur Y, Koren G. Stobie S, et al. Among authors: bentur y. Int J Clin Pharmacol Ther Toxicol. 1993 Dec;31(12):602-5. Int J Clin Pharmacol Ther Toxicol. 1993. PMID: 8314362

10

The effects of subcutaneous deferoxamine administration on renal function in thalassemia major.

Koren G, Kochavi-Atiya Y, Bentur Y, Olivieri NF. Koren G, et al. Among authors: bentur y. Int J Hematol. 1991 Oct;54(5):371-5. Int J Hematol. 1991. PMID: 1756248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters